Common Sense

[Common Sense @unburdenedbeen]

@mlevchin @BrianSozzi I know you're not a fan of your own stock price, but you should be.

[Common Sense @unburdenedbeen]

@nasdaily @aakashgupta get @howardlindzon in on this

[Common Sense @unburdenedbeen]

@xAutonia @nasdaily which stocks would those be?

[Common Sense @unburdenedbeen]

@nasdaily Which companies in particular did you buy

[Common Sense @unburdenedbeen]

@MartinShkreli Surprised nothing has been mentioned by you on $gral

[Common Sense @unburdenedbeen]

@WallStreetMav Bro, you’re right on. Most people just read headlines and act. Like today, $GRAL fell 50 percent because people acted on the headline but if they read further it will show how great their test detects cancer.

[Common Sense @unburdenedbeen]

@davegirouard Com man

[Common Sense @unburdenedbeen]

@afshineemrani @matthewherper @IAmArcIvanov The sensitivity is near perfect and the false positives are extremely tiny. What you noticed is anecdotal.

[Common Sense @unburdenedbeen]

@chamath Chiamato, put your money where it matters. $GRAL study was bloody fantastic! Pun intended. Read the study instead of falling for headlines.

[Common Sense @unburdenedbeen]

@Longfellow45850 @matthewherper Matthew is a shill that wants to see this company fail for some other motives he has. Otherwise, the test results were bloody fantastic!

[Common Sense @unburdenedbeen]

@cameron Rowing? Buy https://t.co/M6iGGwL2hS better than Gemini

[Common Sense @unburdenedbeen]

@AndrewDudum Buy $GRAL stock as a vote of confidence and better price!

[Common Sense @unburdenedbeen]

@cameron What happened to buying the name https://t.co/M6iGGwL2hS since you guys are pro rowers

[Common Sense @unburdenedbeen]

@bio_report It’ll be fda approved, covered by insurance, and become standard

[Common Sense @unburdenedbeen]

@pitdesi You’re a shill

[Common Sense @unburdenedbeen]

@klarnaseb You’re a scammer

[Common Sense @unburdenedbeen]

@AJManaseer I don't think so, but I can admit that I'm not one to know what price it will go to in the near future. Long term it's looking good and I'll buy if it gets lower, as I did today.

[Common Sense @unburdenedbeen]

@bio_report So you believe in the company but think its overvalued?

[Common Sense @unburdenedbeen]

@A_May_MD @robrodrpinto except this product did not fail a clinical trial. the product here works, it detects cancer, and it detects it well. hims is a shit company but grail is not shit.

[Common Sense @unburdenedbeen]

@AJManaseer No, it increased. You missed the point that they are very good at catching early cancer in healthy patients undergoing annual exams. This will be part of the yearly physical.